Ana Carolina Pinto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Carolina Pinto has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Moreira-Gonçalves
University of Porto
2 shared publications - Helena Beatriz Ferreira
Mass Spectrometry Center, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal
2 shared publications - Maria Rosário Marques Domingues
University of Aveiro
2 shared publications - Rita Ferreira
University of Aveiro
2 shared publications - Tânia Melo
University of Aveiro
2 shared publications - Fernando J. Corrales
Functional Proteomics Laboratory, Centro Nacional de Biotecnología-CSIC, Madrid, Spain
1 shared publication
Latest Publications
- 3 October 2026
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 23 (10) , 347-359
Molecular drivers of intercellular communication in physical exercise: insights from omics approaches
1. Exercise training is widely recognized as a healthy practice, being considered a non-pharmacological therapeutic approach for the management of chronic diseases such as cardiovascular diseases, ...
- 3 October 2026
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 23 (10) , 347-359
Molecular drivers of intercellular communication in physical exercise: insights from omics approaches
1. Exercise training is widely recognized as a healthy practice, being considered a non-pharmacological therapeutic approach for the management of chronic diseases such as cardiovascular diseases, ...
- Open Access
- 6 May 2026
- Published by Springer Nature in Metabolomics
- Vol. 22 (3) , 66
Deciphering the circulating lipidome signature associated with physical performance in gastric cancer patients: an exploratory study
Introduction: Physical performance strongly influences peri-treatment outcomes in gastric cancer (GC), yet simple molecular markers reflecting functional status are lacking. Lipidomics may help identify circulating biomarkers linked to physical fitness. Objectives: To assess whether physical performance is associated with distinct plasma lipidomic profiles in GC patients. Methods: Nineteen male GC patients (60–75 years) from the PROTECT trial were classified as high- (HighP) or low-performance (LowP) based on the 6-min walk test. Plasma lipidomics (LC–MS/MS) quantified 232 lipid species and a total of 25 fatty acids were quantified by gas chromatography-MS. Multivariate and univariate analyses, group comparisons, and correlations examined associations with clinical, anthropometric, and fitness parameters. Results: Lipid profiles differed by performance status. HighP patients showed higher phosphatidylinositol (PI 36:2) and trends toward increased plasmalogen phosphatidylethanolamines (PE), whereas sphingomyelin (SM 43:2) was higher in LowP patients. Plasmenyl-PE species correlated positively with functional tests, muscle mass, body mass index, and nutritional status; SM 43:2 correlated negatively. Acylcarnitines showed minimal associations. Conclusion: GC patients with different physical performance status display distinct circulating lipid signatures. PI 36:2, PE plasmalogens, and SM 43:2 species appear linked to physical fitness, suggesting potential value as preoperative biomarkers. Validation in larger cohorts is warranted.
- 6 May 2026
- Published by Springer Nature in Metabolomics
- Vol. 22 (3) , 66
Open AccessDeciphering the circulating lipidome signature associated with physical performance in gastric cancer patients: an exploratory study
Introduction: Physical performance strongly influences peri-treatment outcomes in gastric cancer (GC), yet simple molecular markers reflecting functional status are lacking. Lipidomics may help identify circulating biomarkers linked to physical fitness. Objectives: To assess whether physical performance is associated with distinct plasma lipidomic profiles in GC patients. Methods: Nineteen male GC patients (60–75 years) from the PROTECT trial were classified as high- (HighP) or low-performance (LowP) based on the 6-min walk test. Plasma lipidomics (LC–MS/MS) quantified 232 lipid species and a total of 25 fatty acids were quantified by gas chromatography-MS. Multivariate and univariate analyses, group comparisons, and correlations examined associations with clinical, anthropometric, and fitness parameters. Results: Lipid profiles differed by performance status. HighP patients showed higher phosphatidylinositol (PI 36:2) and trends toward increased plasmalogen phosphatidylethanolamines (PE), whereas sphingomyelin (SM 43:2) was higher in LowP patients. Plasmenyl-PE species correlated positively with functional tests, muscle mass, body mass index, and nutritional status; SM 43:2 correlated negatively. Acylcarnitines showed minimal associations. Conclusion: GC patients with different physical performance status display distinct circulating lipid signatures. PI 36:2, PE plasmalogens, and SM 43:2 species appear linked to physical fitness, suggesting potential value as preoperative biomarkers. Validation in larger cohorts is warranted.